Karyopharm Therapeutics Inc.KPTINASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-53.84%
↑ 99% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-8006.25%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -53.84% | -102.6% |
| 2024 | -26.58% | +67.2% |
| 2023 | -81.09% | +8.6% |
| 2022 | -88.69% | -91.9% |
| 2021 | -46.22% | +70.2% |
| 2020 | -155.30% | +65.3% |
| 2019 | -447.34% | +22.5% |
| 2018 | -577.38% | +92.8% |
| 2017 | -7988.04% | +88.7% |
| 2016 | -70598.05% | - |